IL101014A - Derivatives of 4-pyrimidinone preparation and pharmaceutical preparations containing them - Google Patents

Derivatives of 4-pyrimidinone preparation and pharmaceutical preparations containing them

Info

Publication number
IL101014A
IL101014A IL10101492A IL10101492A IL101014A IL 101014 A IL101014 A IL 101014A IL 10101492 A IL10101492 A IL 10101492A IL 10101492 A IL10101492 A IL 10101492A IL 101014 A IL101014 A IL 101014A
Authority
IL
Israel
Prior art keywords
group
compounds
optionally substituted
ring
formula
Prior art date
Application number
IL10101492A
Other languages
English (en)
Hebrew (he)
Other versions
IL101014A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL101014A0 publication Critical patent/IL101014A0/xx
Publication of IL101014A publication Critical patent/IL101014A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL10101492A 1991-02-20 1992-02-19 Derivatives of 4-pyrimidinone preparation and pharmaceutical preparations containing them IL101014A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102032A FR2672892B1 (fr) 1991-02-20 1991-02-20 Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
IL101014A0 IL101014A0 (en) 1992-11-15
IL101014A true IL101014A (en) 1996-06-18

Family

ID=9409925

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10101492A IL101014A (en) 1991-02-20 1992-02-19 Derivatives of 4-pyrimidinone preparation and pharmaceutical preparations containing them

Country Status (23)

Country Link
EP (1) EP0500409B1 (no)
JP (1) JP2529798B2 (no)
KR (1) KR920016434A (no)
CN (1) CN1034171C (no)
AT (1) ATE135695T1 (no)
AU (1) AU650319B2 (no)
CA (1) CA2061456A1 (no)
CS (1) CS49092A3 (no)
DE (1) DE69209113T2 (no)
DK (1) DK0500409T3 (no)
ES (1) ES2086090T3 (no)
FI (1) FI920720A (no)
FR (1) FR2672892B1 (no)
GR (1) GR3019404T3 (no)
HU (2) HUT60477A (no)
IE (1) IE76145B1 (no)
IL (1) IL101014A (no)
MX (1) MX9200690A (no)
NO (1) NO920648L (no)
NZ (1) NZ241659A (no)
PL (1) PL168617B1 (no)
RU (1) RU2073675C1 (no)
ZA (1) ZA921203B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
FR2700543B1 (fr) * 1993-01-15 1995-03-17 Synthelabo Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US8592431B2 (en) * 2009-01-30 2013-11-26 Takeda Pharmaceutical Company Limited Fused ring compound and use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
DE69025473T2 (de) * 1989-06-30 1996-10-17 Du Pont Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
EP0522038A4 (en) * 1990-03-30 1993-05-26 Merck & Co. Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
IE912114A1 (en) * 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
PL168617B1 (pl) 1996-03-29
ES2086090T3 (es) 1996-06-16
JPH04346980A (ja) 1992-12-02
CN1064269A (zh) 1992-09-09
IE920525A1 (en) 1992-08-26
DK0500409T3 (da) 1996-07-15
FR2672892A1 (fr) 1992-08-21
HU211886A9 (en) 1995-12-28
IE76145B1 (en) 1997-10-08
PL293531A1 (en) 1992-08-24
CA2061456A1 (en) 1992-08-21
CS49092A3 (en) 1992-09-16
EP0500409A1 (fr) 1992-08-26
KR920016434A (ko) 1992-09-24
RU2073675C1 (ru) 1997-02-20
FR2672892B1 (fr) 1994-01-14
HU9200532D0 (en) 1992-05-28
ATE135695T1 (de) 1996-04-15
MX9200690A (es) 1992-08-01
FI920720A (fi) 1992-08-21
JP2529798B2 (ja) 1996-09-04
EP0500409B1 (fr) 1996-03-20
DE69209113T2 (de) 1996-10-31
HUT60477A (en) 1992-09-28
NO920648L (no) 1992-08-21
NZ241659A (en) 1993-03-26
DE69209113D1 (de) 1996-04-25
AU650319B2 (en) 1994-06-16
FI920720A0 (fi) 1992-02-19
CN1034171C (zh) 1997-03-05
ZA921203B (en) 1992-11-25
AU1105992A (en) 1992-08-27
GR3019404T3 (en) 1996-06-30
NO920648D0 (no) 1992-02-19
IL101014A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
AU672679B2 (en) Substituted mono- and bipyridylmethylpyridones
US5336677A (en) Substituted aminopyrimidines as antihypertensives
US5210211A (en) 4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
PT95929A (pt) Processo para a prparacao de derivados de diazina e de composicoes farmaceuticas que os contem
SK278797B6 (sk) Substituované azoly, spôsob ich výroby, ich použit
EP0443568A1 (en) Fused thiophene derivatives, their production and use
JPH04230370A (ja) アンギオテンシンii受容体拮抗剤である新規ピリミジン誘導体、それらの製造方法およびそれらを含む薬剤組成物
US5354749A (en) Sulfonylbenzyl-substituted benzo- and pyridopyridones
IL101014A (en) Derivatives of 4-pyrimidinone preparation and pharmaceutical preparations containing them
AU651740B2 (en) Quinoline derivatives, process for their preparation, and their therapeutic applications
JPH07500345A (ja) アンジオテンシン2拮抗剤としてのピリミドシクロアルカン類
US5407942A (en) Biphenylmethyl-substituted pyridones
US5472967A (en) 4-pyrimidinone derivatives their preparation and their application in therapy
JPH05255327A (ja) 複素環式誘導体
JPH05186462A (ja) 複素環式化合物、その製造方法および該化合物を含有する高血圧症およびうつ血性心麻痺用の医薬調剤
US5284661A (en) Fused thiophene derivatives, their production and use
AU670487B2 (en) Heterotricyclically substituted phenyl-cyclohexane- carboxylic acid derivatives
US5594010A (en) Substituted monopyridylmethyl derivatives
ITMI940296A1 (it) Derivati eterociclici diazotati aventi attivita' aii antagonista
US5576342A (en) Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
US5457112A (en) 3-(6-quinolylmethyl)-4H-imidazol-4-one derivatives, their preparation and their application in therapy
CA2090281A1 (en) Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives
JPH0625250A (ja) チエノ〔3,4−d〕イミダゾール誘導体、その製造法およびそれを含有する循環器官用剤
US5530016A (en) Substituted 2,4-imidazolidinediones
WO1995016677A1 (fr) Nouveau derive de pyrimidine et composition medicinale

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees